Canopy Growth Announces Medical Cannabis Supply Deal in the United Kingdom
Canopy Growth Corporation (NASDAQ:CGC) has entered into a supply agreement with GROW Group U.K. Ltd., enabling the distribution of four Canadian-grown medical cannabis flower strains to the UK market under its Spectrum Therapeutics brand. This marks Canopy's first introduction of these products in Europe and is part of broader efforts to expand its European operations. The partnership leverages GROW Group’s existing network for distributing prescribed cannabis-based medicines across Europe, enhancing Canopy Growth's international footprint without disclosing financial terms or a specific launch date. The agreement follows the renewal of EU Good Manufacturing Practice (GMP) certification at Canopy’s Ontario facility, reinforcing its compliance and ability to supply European markets. Canopy CEO Luc Mongeau emphasized that this move is an important step in expanding their medical cannabis business across Europe.
Tickers: $CGC